Scott Bradley Silverman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid-Cavernous Sinus Fistula | 2 | 2023 | 37 | 1.380 |
Why?
|
| Carotid Stenosis | 4 | 2022 | 853 | 0.800 |
Why?
|
| Endarterectomy, Carotid | 2 | 2022 | 549 | 0.680 |
Why?
|
| Ischemic Attack, Transient | 3 | 2022 | 878 | 0.660 |
Why?
|
| Embolization, Therapeutic | 2 | 2023 | 1407 | 0.510 |
Why?
|
| Cerebral Angiography | 4 | 2023 | 1275 | 0.400 |
Why?
|
| Stroke | 7 | 2023 | 9696 | 0.370 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2021 | 136 | 0.350 |
Why?
|
| Cerebral Hemorrhage | 3 | 2023 | 2650 | 0.340 |
Why?
|
| Vision Disorders | 1 | 2016 | 1084 | 0.320 |
Why?
|
| Dyskinesias | 1 | 2023 | 79 | 0.210 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 26 | 0.200 |
Why?
|
| Unconsciousness | 1 | 2023 | 250 | 0.190 |
Why?
|
| Vertebral Artery | 1 | 2021 | 185 | 0.180 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2021 | 111 | 0.180 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2020 | 42 | 0.180 |
Why?
|
| Cerebral Arteries | 1 | 2021 | 492 | 0.160 |
Why?
|
| Intracranial Hemorrhages | 1 | 2022 | 820 | 0.130 |
Why?
|
| Thrombectomy | 1 | 2020 | 690 | 0.130 |
Why?
|
| Carotid Artery, Internal | 1 | 2018 | 435 | 0.130 |
Why?
|
| Siderosis | 1 | 2016 | 103 | 0.120 |
Why?
|
| Fibrinolytic Agents | 2 | 2022 | 2071 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2021 | 1431 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2022 | 2747 | 0.100 |
Why?
|
| Clinical Protocols | 1 | 2018 | 1436 | 0.100 |
Why?
|
| Recurrence | 3 | 2023 | 8426 | 0.100 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 2060 | 0.100 |
Why?
|
| Foramen Ovale, Patent | 1 | 2013 | 208 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 1944 | 0.090 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2016 | 892 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2022 | 64379 | 0.070 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 2139 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 1647 | 0.070 |
Why?
|
| Risk Factors | 7 | 2023 | 73806 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2022 | 4778 | 0.070 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2007 | 177 | 0.070 |
Why?
|
| Brain | 1 | 2012 | 26951 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2018 | 3047 | 0.060 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2007 | 269 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 5105 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 58681 | 0.060 |
Why?
|
| Time Factors | 5 | 2020 | 39873 | 0.060 |
Why?
|
| Dystonia | 1 | 2007 | 366 | 0.050 |
Why?
|
| Humans | 17 | 2023 | 758381 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2022 | 80170 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 15785 | 0.050 |
Why?
|
| Dexmedetomidine | 1 | 2007 | 316 | 0.050 |
Why?
|
| Registries | 1 | 2017 | 8176 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 5759 | 0.040 |
Why?
|
| Male | 13 | 2023 | 358742 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 3339 | 0.040 |
Why?
|
| Aged | 9 | 2023 | 168217 | 0.040 |
Why?
|
| Heart Failure | 1 | 2023 | 11594 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 7810 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 54136 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2021 | 604 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 172 | 0.030 |
Why?
|
| Disease Progression | 1 | 2012 | 13468 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2021 | 7980 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 584 | 0.030 |
Why?
|
| Female | 9 | 2023 | 390316 | 0.030 |
Why?
|
| Brain Injuries | 1 | 2007 | 2044 | 0.030 |
Why?
|
| Embolism, Paradoxical | 1 | 2013 | 54 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15225 | 0.030 |
Why?
|
| Septal Occluder Device | 1 | 2013 | 125 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 36285 | 0.030 |
Why?
|
| Middle Aged | 7 | 2021 | 219560 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2048 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 2850 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 1436 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2018 | 1825 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 2731 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2971 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2013 | 795 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 20500 | 0.020 |
Why?
|
| Stents | 1 | 2020 | 3162 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 1031 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1475 | 0.020 |
Why?
|
| Length of Stay | 1 | 2018 | 6439 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3227 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6493 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10495 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9266 | 0.010 |
Why?
|
| Patient Selection | 1 | 2013 | 4244 | 0.010 |
Why?
|
| Migraine Disorders | 1 | 2013 | 1694 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29558 | 0.010 |
Why?
|
| Boston | 1 | 2013 | 9304 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23883 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 22031 | 0.010 |
Why?
|
| Adult | 3 | 2021 | 219916 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 41252 | 0.010 |
Why?
|